日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

一项针对晚期胰腺癌或结直肠癌患者的BMS-813160(一种CCR2/5双重拮抗剂)联合化疗或纳武利尤单抗的1b/2期研究

Le, Dung T; Folprecht, Gunnar; Varghese, Anna M; Gutierrez, Martin; Noel, Marcus; Trikalinos, Nikolaos A; Chen, Eric; Dayyani, Farshid; Davis, S Lindsey; Ma, Wen Wee; BasuMallick, Atrayee; Garrido-Laguna, Ignacio; Osawa, Mayu; O'Brien, Shaun; Novosiadly, Ruslan D; Xu, Ke; Greenawalt, Danielle M; Dutta, Santanu; Twyman Saint Victor, Christina; Lenz, Heinz-Josef

Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers

循环肿瘤DNA可指导复发/转移性胃食管癌患者的临床实践

Mehta, Rutika; Rivero-Hinojosa, Samuel; Dayyani, Farshid; Ferguson, Jenifer; Shariff, Bushra; Aushev, Vasily N; Budde, Griffin L; Ortiz, J Bryce; George, Giby V; Sharma, Shruti; Jurdi, Adham A; Liu, Minetta C; Drengler, Ronald L; Klempner, Samuel J

Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy

循环肿瘤DNA在评估接受新辅助治疗的局部晚期直肠癌患者的肿瘤反应中的应用

Chakrabarti, Sakti; Cohen, Stacey A; Tin, Antony; Dangl, Autumn; Chung, Ki Y; Tejani, Mohamedtaki A; Fakih, Marwan G; Chandana, Sreenivasa R; Donahue, Colleen A; George, Virgilio; Malla, Midhun; Aushev, Vasily N; George, Giby V; Ortiz, J Bryce; Herter, Whitney K; Nagarajan, Arun; Weinberg, Benjamin A; Sharma, Vivek R; Botta, Gregory P; Cho, May; Azzi, Georges; Kasi, Anup; Dayyani, Farshid; Hanna, Diana L; Somer, Bradley G; Malhotra, Meenakshi; Sharma, Shruti; Jurdi, Adham; Liu, Minetta C; Landmann, Ron G; Dasari, Arvind

Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal Metastases

用于治疗不可切除的伴有腹膜转移的结直肠腺癌的区域性疗法

Malik, Shray; Le, Vanessa; Dayyani, Farshid; Senthil, Maheswari; Eng, Oliver S; O'Leary, Michael P

Underutilization of Staging Laparoscopy Prior to Neoadjuvant Systemic Therapy in Gastric Cancer

胃癌新辅助全身治疗前分期腹腔镜检查利用不足

Ostowari, Arsha; Chen, Kathryn T; Hasjim, Bima J; Montero, Stefania; Sedighim, Shaina; Tajik, Fatemeh; Roman, Melanie; Dayyani, Farshid; Daly, Shaun; Smith, Brian R; Nguyen, Ninh T; Eng, Oliver S; O'Leary, Michael P; Senthil, Maheswari

The association between adherence to elective nodal volume guidelines and reduced distant metastasis in esophageal and gastroesophageal junction cancer: a retrospective analysis of elective nodal irradiation

选择性淋巴结照射量指南的遵循与食管癌和胃食管交界处癌远处转移减少之间的关联:选择性淋巴结照射的回顾性分析

Lyons, Jared; Harada, Garrett; Yeakel, John; Dayyani, Farshid; Smith, Brian; Daly, Shaun; Nguyen, Ninh; Keshava, Harada; Dufault, Suzanne; Hui, Caressa; Hotca, Alexandra; Seyedin, Steven

A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors

Givastomig(一种 CLDN18.2 和 4-1BB 双特异性抗体)作为单药疗法治疗 CLDN18.2 阳性晚期或转移性实体瘤患者的首次人体研究

Ku, Geoffrey; Shen, Lin; Dayyani, Farshid; Kratz, Jeremy; Liang, Xinjun; Liu, Funan; Wang, Zhenning; Feller, Laura; Girda, Eugenia; Pan, Hongming; Kim, Sunnie; Deng, Yanhong; Deng, Ting; Liu, Tianshu; Powderly, John; Spencer, Kristen; Schneider, Reva; Berlin, Jordan; Xu, Claire Cong; Ahlers, Christoph M; Liu, Xuejun; Chung, Jou-Ku; Sabbatini, Peter; Park, Jinyoung; Lim, Yangmi; Jeon, Juyeun; Meng, Yuan; Klempner, Samuel J

Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells

利用经典树突状细胞和自然杀伤T细胞治疗结直肠癌的细胞免疫疗法前景广阔

Singer, Mahmoud; Valerin, Jennifer; Zhang, Zhuoli; Zhang, Zigeng; Dayyani, Farshid; Yaghmai, Vahid; Choi, April; Imagawa, David; Abi-Jaoudeh, Nadine

Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study

吉西他滨化疗治疗晚期胆道癌患者的治疗模式和预后:一项回顾性研究

Dayyani, Farshid; Stirnadel-Farrant, Heide A; Hu, Jenny; Lin, Yian; Kebede, Nehemiah; Valerio, Stephen J; Ahn, Daniel H

Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors

针对晚期实体瘤患者的 zavondemstat (TACH101)(一种首创的 KDM4 抑制剂)的 1 期研究

Tsimberidou, Apostolia M; Dayyani, Farshid; Sommerhalder, David; Vandross, Andrae L; Pelster, Meredith S; Henry, Jason T; Perez, Cesar A; Chakraborty, Abhijit; Baysal, Mehmet A; Chandhasin, Chandtip; Dai, Yiyun; Tu, Shirley; King, Ivan; Perabo, Frank